<DOC>
	<DOCNO>NCT01545037</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness Bio-K+ symptom IBS .</brief_summary>
	<brief_title>Effect BIO-K+ Symptoms Irritable Bowel Syndrome</brief_title>
	<detailed_description>Given promising clinical result previous trial probiotic IBS symptom , objective clinical trial evaluate safety effectiveness proprietary probiotic product , Lactobacillus acidophilus CL1285® Lactobacillus casei LBC80R® , symptom IBS otherwise healthy adult .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>1 . Age 18 year old 2 . Subject meet Rome III criterion IBS ( regardless IBS subtype ) follow : Recurrent abdominal pain discomfort least 3 days/month last 3 month associate 2 follow : Improvement defecation Onset associate change frequency stool Onset associate change form ( appearance ) stool Symptom onset must least 6 month prior diagnosis 3 . Agree use contraception throughout study period , unless postmenopausal surgically sterile ( female ) 4 . Able understand nature purpose study include potential risk side effect 5 . Willing consent study participation comply study requirement Abdominal pain discomfort least 2 day runin period associate 2 following : Improvement defecation Onset associate change frequency stool Onset associate change form ( appearance ) stool Completion studyrelated questionnaire 1 . Diagnosed gastrointestinal disease , e.g . Crohn 's disease , ulcer , cancer 2 . Prior abdominal surgery , investigator 's opinion , may confound study outcomes 3 . Any systemic disease may confound IBS symptom compromise subject safety 4 . Life expectancy &lt; 6 month 5 . Pregnant female breastfeed 6 . Lactose intolerance 7 . Immunodeficient subject 8 . Uncontrolled psychiatric disorder 9 . Current treatment nasogastric tube , ostomy , parenteral nutrition 10 . Eating disorder 11 . Recent ( &lt; 2 week ) antibiotic administration 12 . History alcohol , drug , medication abuse 13 . Daily consumption probiotic , ferment milk , and/or yogurt 14 . Known allergy substance study product 15 . Participation another study investigational product within 3 month screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>